Deborah Eva Citrin MD

Radiation Oncology•Bethesda, MD

Physician

Join to View Full Profile

10 Rockville Pike# 10Bethesda, MD 20892
Phone+1 301-496-5457

Education & Training

Duke University School of MedicineClass of 2000

Certifications & Licensure

MD State Medical License 2001 - 2026
VA State Medical License 2008 - 2026
American Board of Radiology Radiation Oncology

Clinical Trials

A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies Start of enrollment: 2007 Feb 01
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin Start of enrollment: 2009 Apr 23
COMPLETED
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum Start of enrollment: 2010 May 24
Terminated
Phase 1
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer Start of enrollment: 2011 Mar 18
Terminated
Phase 1
ECI301 and Radiation for Advanced or Metastatic Cancer Start of enrollment: 2011 Sep 06
Terminated
Phase 1
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers Start of enrollment: 2007 Feb 20
Terminated
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy Start of enrollment: 2013 Nov 13
RECRUITING
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy Start of enrollment: 2018 Jul 05
ACTIVE_NOT_RECRUITING
PHASE1
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy Start of enrollment: 2018 Jan 17
Active, not recruiting
Phase 1
A Study of Patients Receiving High-Dose Rate Brachytherapy Start of enrollment: 2009 Apr 14
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer Start of enrollment: 2021 Oct 01
Recruiting
Phase 1
Roles: Principal Investigator, Contact
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy Start of enrollment: 2022 Aug 31
RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer Start of enrollment: 2024 Feb 15
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Interleukin-13 Receptor Subunit Alpha 2 Induces Chemokine Expression and Macrophage Polarization to Promote Inflammation and Fibrosis.
Seokjoo Kwon, Eun Joo Chung, Santwana Kc, Ayla O White, Su I Chung
International Journal of Radiation Oncology, Biology, Physics. 2025-04-01
Radiotherapy toxicities: mechanisms, management, and future directions.
Ioannis I Verginadis, Deborah E Citrin, Bonnie Ky, Steven J Feigenberg, Alexandros G Georgakilas
Lancet. 2025-01-25
The Determinants of Toxicity in the Treatment of Prostate Cancer With a Focal, Intraprostatic "Microboost".
Krishnan R Patel, Alan Dal Pra, Erich P Huang, Sarah A Singh, Vivek Verma
International Journal of Radiation Oncology, Biology, Physics. 2025-01-23

Press Mentions

GE HealthCare Showcases the Latest AI-Enhanced Radiation Therapy Solutions at ASTRO 2024September 26th, 2024
Alessa Therapeutics Announces IND Clearance for a Study in Collaboration with the National Cancer InstituteJune 7th, 2021
Can Low-Dose Radiotherapy Treat COVID-19-Related Pneumonia?November 3rd, 2020